de Arazoza HA, Rodríguez RE, Rodríguez SFL, Cruz BR, Fernández MA

Language: Spanish
References: 20
Page: 64-72
PDF size: 184.25 Kb.

ABSTRACT

Introduction: therapies of anti coagulation and anti aggregation are frequently used in cardiopath patients. The anesthetic conduction of these patients has some peculiarities which in case they are not fulfilled they may lead to severe complications or even the death of the patient.
Objective: to revise the anesthetic conduct in front of cardiopath patients and is anti coagulated for elective or emergent non cardiac surgery.
Method: a revision of the characteristics of this patient was carried out, the causes of anti coagulation were analyzed , the causes of anti coagulation were analyzed as well as the causes of anti coagulation and the interruption or not of the anti coagulant treatment ante main, minor, elective or urgent procedures. The intra operative monitoring is detailed and the reinitiating of post surgery anti coagulant treatment.
Conclusion: the success of the non cardiac surgery of the cardiopath patient and takes an anti coagulant treatment is only possible thanks to the knowledge and fulfillment of particularities of this patient. It is not possible to improvise with these cases which explain a great medical legal responsibility for the anesthesiologist.

REFERENCES

1. Bonow RO, Carabello BA, Chatterjee K et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. J Am Coll Cardiol 2006;48:1148.

2. Rahimtoola SH. Choice ofprosthetic heart valve for adult patients. J Am Coll Cardiol 2003;41:893904.

3. Rahimtoola SH. The year in valvular heart disease. J Am Coll Cardiol 2005;45:11122.

4. Carabello B.A.: Clinicalpractice. Aortic stenosis. N Engl J Med 2002; 346:677.

5. Carabello B.A.: The pathophysiology of mitral regurgitation. J Heart Valve Dis 2000; 9:600.

6. Guyatt GH. Executive Summary. Therapy and prevention of thrombosis, 9th edition. American College of Chest Physicians. Evidence-Based Clinical Practice Guidelines. Chest 2012;141;7S-47S. En línea. [Consultada agosto 15, 2013]. URL disponible en: http://chestjournal.chestpubs.org/content/141/2_suppl/7S.full.html

7. Holbrook A, Schulman S, Witt DM, et al. Evidence-based management of anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012;141(2)(suppl):e152S-e184S.

8. Ufer M. Comparative pharmacokinetics of vitamin K antagonists: warfarin, phenprocoumon and acenocumarol. Clin Pharmacokinet. 2005;44:1227-46.

9. Palareti G, Cosmi B. Bleeding with anticoagulation therapy Who is at risk, and how best to identify such patients. Thromb Haemost. 2009;102(2):268-78.

10. Hannan E.L., Kilburn Jr. H., O'Donnell J.F., et al: Adult open heart surgery in New York State: An analysis of risk factors and hospital mortality rates. JAMA 1990; 264:2768.

11. Crescenzi G., Scandroglio A.M., Pappalardo F., et al: ECG changes after CABG: The role of the surgical technique. J Cardiothorac Vasc Anesth 2004; 18:38.

12. ACC/AHA: 2007 Guidelines on perioperative cardiovascular evaluation & care for noncardiac surgery. J Am Coll Cardiol 2007; 50:1707-1732.

13. Warkentin TE, Crowther MA. Reversing anticoagulants both old and new. Can J Anaesth 2002; 49:S11.

14. Dorje P, Tremper K. Systolic pressure variation: A dynamic measure of the adequacy of intravascular volume. Semin Anesth Periop Med Pain 2005; 24:147.

15. Vender J.: Pulmonary artery catheter utilization: The use, misuse, or abuse. J Cardiothorac Vasc Anesth 2006; 20:295-299.

16. American Society of Anesthesiologists Task Force on Pulmonary Artery Catheterization: Practice guidelines for pulmonary artery catheterization: An updated report by the American Society of Anesthesiologists Task Force on Pulmonary Artery Catheterization. Anesthesiology 2003; 99:988.

17. Spiess BD, Gillies BS, Chandler W, Verrier E. Changes in transfusion therapy and reexploration rate after institution of a blood management program in cardiac surgical patients. J Cardiothorac Vasc Anesth 1995; 9:168.

18. Bonow RO, Picone AL, McIntosh CL, Jones M, Rosing DR,Maron BJ et al. Survival and functional results after valve replacementfor aortic regurgitation from 1976 to 1983. Impact ofpreoperative left ventricular function. Circulation 1985; 72:1244-1256.

19. Kaplan, JA. Essentials of Cardiac Anesthesia, 1st ed. 2008. Ed. Saunders. New York. pp 123-134.

20. DiNardo JA, Zvara DA. Anesthesia for Cardiac Surgery. Third ed, 2008.Published by Blackwell Publishing Inc, 350 Main Street, Malden, Massachusetts 02148-5020, USA. pp. 334-342.